Schrag SJ - Search Results

1

The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.

Samai M, Seward JF, Goldstein ST, Mahon BE, Lisk DR, Widdowson MA, Jalloh MI, Schrag SJ, Idriss A, Carter RJ, Dawson P, Kargbo SAS, Leigh B, Bawoh M, Legardy-Williams J, Deen G, Carr W, Callis A, Lindblad R, Russell JBW, Petrie CR, Fombah AE, Kargbo B, McDonald W, Jarrett OD, Walker RE, Gargiullo P, Bash-Taqi D, Gibson L, Fofanah AB, Schuchat A; STRIVE Study Team. Samai M, et al. Among authors: schrag sj. J Infect Dis. 2018 May 18;217(suppl_1):S6-S15. doi: 10.1093/infdis/jiy020. J Infect Dis. 2018. PMID: 29788345 Free PMC article. Clinical Trial.

2

Neonatal group B streptococcal disease: how infection control teams can contribute to prevention efforts.

Schrag SJ, Whitney CG, Schuchat A. Schrag SJ, et al. Infect Control Hosp Epidemiol. 2000 Jul;21(7):473-83. doi: 10.1086/501791. Infect Control Hosp Epidemiol. 2000. PMID: 10926399 Review.

3

Early opportunities for prevention: infections of pregnant women and young infants.

Schuchat A, Hillier S, Edwards K, Schrag S, Labbok M. Schuchat A, et al. Emerg Infect Dis. 2001;7(3 Suppl):532. doi: 10.3201/eid0707.017711. Emerg Infect Dis. 2001. PMID: 11485649 Free PMC article. No abstract available.

4

Sentinel surveillance: a reliable way to track antibiotic resistance in communities?

Schrag SJ, Zell ER, Schuchat A, Whitney CG. Schrag SJ, et al. Emerg Infect Dis. 2002 May;8(5):496-502. doi: 10.3201/eid0805.010268. Emerg Infect Dis. 2002. PMID: 11996685 Free PMC article.

5

A human papillomavirus type 16 vaccine.

Schrag SJ, Schuchat A, Schulkin J. Schrag SJ, et al. N Engl J Med. 2003 Apr 3;348(14):1402-5; author reply 1402-5. N Engl J Med. 2003. PMID: 12678020 No abstract available.

6

Effects of intrapartum antimicrobial prophylaxis for prevention of group-B-streptococcal disease on the incidence and ecology of early-onset neonatal sepsis.

Moore MR, Schrag SJ, Schuchat A. Moore MR, et al. Among authors: schrag sj. Lancet Infect Dis. 2003 Apr;3(4):201-13. doi: 10.1016/s1473-3099(03)00577-2. Lancet Infect Dis. 2003. PMID: 12679263 Review.

7

Vaccination and perinatal infection prevention practices among obstetrician-gynecologists.

Schrag SJ, Fiore AE, Gonik B, Malik T, Reef S, Singleton JA, Schuchat A, Schulkin J. Schrag SJ, et al. Obstet Gynecol. 2003 Apr;101(4):704-10. doi: 10.1016/s0029-7844(03)00010-3. Obstet Gynecol. 2003. PMID: 12681874

8

Report from the CDC. Awareness of perinatal group B streptococcal infection among women of childbearing age in the United States, 1999 and 2002.

Cowgill K, Taylor TH Jr, Schuchat A, Schrag S. Cowgill K, et al. J Womens Health (Larchmt). 2003 Jul-Aug;12(6):527-32. doi: 10.1089/154099903768248221. J Womens Health (Larchmt). 2003. PMID: 13678508

9

Prenatal screening for infectious diseases and opportunities for prevention.

Schrag SJ, Arnold KE, Mohle-Boetani JC, Lynfield R, Zell ER, Stefonek K, Noga H, Craig AS, Thomson Sanza L, Smith G, Schuchat A. Schrag SJ, et al. Obstet Gynecol. 2003 Oct;102(4):753-60. doi: 10.1016/s0029-7844(03)00671-9. Obstet Gynecol. 2003. PMID: 14551005

10

Easing the burden: characterizing the disease burden of neonatal group B streptococcal disease to motivate prevention.

Schrag SJ, Schuchat A. Schrag SJ, et al. Clin Infect Dis. 2004 May 1;38(9):1209-11. doi: 10.1086/382889. Epub 2004 Apr 14. Clin Infect Dis. 2004. PMID: 15127329 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters